The endoscopy device industry in Benelux plays a vital role in innovative medical technologies. It encompasses companies focused on developing diagnostic and therapeutic tools for minimally invasive procedures. This sector includes manufacturers of imaging systems, catheters, and surgical instruments tailored to various medical fields, particularly gastroenterology and pulmonology. As healthcare continues to evolve, the demand for advanced, efficient endoscopy solutions is increasing, driven by a growing focus on patient-centered care and early disease detection. Notably, trends such as the integration of artificial intelligence and automation are shaping the future of endoscopy devices, enhancing precision and outcomes for patients.


The list of investors includes a mix of venture capital and private equity firms, predominantly based in the Benelux region, specifically in cities like Amsterdam and Brussels. These firms vary significantly in size, ranging from small teams to large organizations with hundreds of staff. Most were founded between the 1980s and 2010s, with a noticeable emphasis on technology and healthcare investments reflected in their deal counts for 2024. Each has committed to fostering growth in innovative sectors, contributing a total of 300 deals in the endoscopy device space, highlighting their active pursuit of promising technologies.


Top 19 Endoscopy Device Investors in Benelux


1. European Innovation Council (EIC)


The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, the EIC offers various funding programs, including the EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale their technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation across different sectors. Among its notable transactions, the EIC has invested in MiWendo, which raised funds through grants, and Colospan, a company developing solutions for colorectal surgery, which received €8.2 million as part of the EIC Accelerator program. Colospan's device, CG-100, has been approved for use in the EU and Israel, and is under IDE in the USA, highlighting the EIC's involvement in advancing medical technologies relevant to endoscopy.


2. European Investment Bank (EIB)


The European Investment Bank (EIB) is a public entity based in Luxembourg, founded in 1958, that provides financial services including loans, equity investments, guarantees, and advisory services to support sustainable projects across various sectors. EIB's clientele includes both public and private organizations seeking funding for initiatives that promote growth and job creation. Notably, EIB has participated in financing rounds for companies in the endoscopy device sector, such as Robocath, which raised approximately $17 million in debt financing in December 2021, and Quantum Surgical, which secured a 40 million Euro financing round in October 2021, with EIB contributing to this funding. These transactions highlight EIB's engagement in the medical technology space, particularly in endoscopy-related innovations, demonstrating its role as a significant investor in this field.


3. Life Sciences Partners (LSP)

  • Website: lspvc.com
  • Type: Venture Capital
  • Headquarters: Amsterdam, North Holland, Netherlands
  • Founded year: 1987
  • Headcount: 11-50
  • Number of deals in 2024: 15
  • LinkedIn: lsp-bioventures

Life Sciences Partners (LSP) is a venture capital firm based in Amsterdam, Netherlands, specializing in private equity investments within the healthcare sector. Founded in 1987, LSP connects investors with innovative healthcare companies, focusing on drug development and medical technology. The firm aims to foster advancements in healthcare that address unmet medical needs by providing capital and support. Notably, LSP has been involved in several significant transactions, including investments in LUMA Vision, a company developing advanced imaging technologies, and Cardiac Dimensions, which focuses on cardiac devices. These investments highlight LSP's commitment to supporting innovative medical technologies, which may include applications relevant to endoscopy devices.


4. Gilde Healthcare


Gilde Healthcare is a venture capital firm based in Utrecht, Netherlands, founded in 1982. It specializes in healthcare investments, managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. The firm focuses on innovative healthtech and therapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Notable transactions include multiple funding rounds for Vapotherm, a manufacturer of advanced respiratory care devices, and Axonics Modulation Technologies, which raised significant capital for its medical technologies. While these transactions do not specifically highlight endoscopy devices, Gilde Healthcare's commitment to healthtech positions it as a potential investor in the endoscopy device sector.


5. Brabantse Ontwikkelings Maatschappij (BOM)


Brabantse Ontwikkelings Maatschappij (BOM) is a venture capital firm based in Tilburg, North Brabant, Netherlands, founded in 1983. BOM is dedicated to supporting startups and scale-ups in the Brabant region through various programs aimed at enhancing business growth, including readiness programs for venture capital and innovation in sustainable sectors. They provide funding, expertise, and networking opportunities to facilitate success in competitive markets. BOM has been involved in several notable transactions in the medical technology sector, including investments in SamanTree Medical, which raised $14 million in Series B funding to commercialize its Histolog™ system for cancer surgery, and Microsure, which raised €38 million in Series B2 funding for its robot-assisted microsurgery technology. These investments highlight BOM's commitment to advancing medical innovations, particularly in areas that could relate to endoscopy devices.


6. Gimv

  • Website: gimv.com
  • Type: Venture Capital
  • Headquarters: Antwerp, Flanders, Belgium
  • Founded year: 1980
  • Headcount: 51-200
  • Number of deals in 2024: 8
  • LinkedIn: gimv

Gimv is a venture capital investment firm based in Antwerp, Flanders, Belgium, founded in 1980. The firm partners with innovative companies across various sectors, including Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. Gimv provides investment management and strategic support to help businesses grow sustainably, primarily targeting entrepreneurial companies seeking capital and expertise to navigate market challenges. Notably, Gimv has participated in significant transactions within the healthcare sector, including a Series D financing round for EndoStim, Inc., which focuses on minimally-invasive GERD therapy, highlighting their engagement in the endoscopy device space. Additionally, their involvement in JenaValve Technology, which develops transcatheter aortic valve implantation systems, further underscores their commitment to medical devices. These transactions illustrate Gimv's active role in supporting innovative healthcare solutions, making them a relevant player in the endoscopy device industry.


7. Noshaq

  • Website: noshaq.be
  • Type: Venture Capital
  • Headquarters: Belgium
  • Founded year: 1985
  • Headcount: 11-50
  • Number of deals in 2024: 11
  • LinkedIn: noshaq-be

Noshaq is a venture capital investment fund based in Belgium, founded in 1985, that provides financial solutions and strategic support to small and medium-sized enterprises (SMEs) in the province of Liege. The firm focuses on funding, project structuring, and business development, particularly in sectors such as biotech and sustainable development. Noshaq aims to foster growth and innovation by actively engaging with its clients and offering tailored financial assistance. Notably, Noshaq has participated in several significant transactions in the MedTech space, including a $14 million Series B investment in SamanTree Medical in July 2024, and a €12 million equity funding round for Intressa Vascular, a clinical-stage MedTech company, completed between October 2021 and October 2022. Additionally, they have been involved in multiple funding rounds for Miracor Medical, a company focused on developing medical devices, including a $28 million Series E round in September 2020. These transactions highlight Noshaq's active role in the MedTech sector, particularly in companies that may have applications in endoscopy devices.


8. NLC - The European Healthtech Venture Builder

  • Website: nlc.health
  • Type: Corporate
  • Headquarters: Amsterdam, North Holland, Netherlands
  • Founded year: 2014
  • Headcount: 51-200
  • Number of deals in 2024: 6
  • LinkedIn: nlc-next-level-challenge

NLC - The European Healthtech Venture Builder is a corporate investor based in Amsterdam, Netherlands, founded in 2014. They focus on developing medical technology solutions, particularly in the healthcare sector. NLC Health has been involved in several transactions, including a notable investment in Scinvivo, which is working on improving catheter and OCT systems for clinical use, directly linking them to the endoscopy device industry. They also invested in Ansana, which is developing alpha-prototypes and regulatory strategies, although not directly related to endoscopy. Their business model emphasizes collaboration with healthcare providers and investors to drive innovation, making them a significant player in the healthtech space.


9. Exor N.V.

  • Website: exor.com
  • Type: Venture Capital
  • Headquarters: Amsterdam, North Holland, Netherlands
  • Founded year: 2009
  • Headcount: 11-50
  • Number of deals in 2024: 26
  • LinkedIn: exor_2

Exor N.V. is a holding company based in Amsterdam, Netherlands, founded in 2009. It operates across various sectors, including automotive, healthcare, and media, and manages a diverse portfolio of companies such as Ferrari, Stellantis, and Philips. Exor focuses on enhancing value through strategic investments and operational support. In the healthcare sector, Exor has participated in several notable transactions, including Kheiron Medical Technologies, which raised $22 million to conduct large-scale clinical trials for its technology, and Allotex, which secured $30 million for developing its refractive error treatment technology. These investments highlight Exor's commitment to advancing medical technologies, making it a relevant investor in the endoscopy device industry.


10. Cvc

  • Website: cvc.com
  • Type: Private Equity
  • Headquarters: Luxembourg
  • Founded year: 2005
  • Headcount: 1001-5000
  • Number of deals in 2024: 16
  • LinkedIn: cvc-capital-partners

CVC Capital Partners is a prominent private equity firm based in Luxembourg, founded in 2005. The firm specializes in private equity, credit, secondaries, and infrastructure, managing approximately €193 billion in assets for over 1000 clients, including pension funds and institutional investors. CVC focuses on delivering sustainable value and growth through strategic investments. Notably, CVC has made significant investments in the medical device sector, including the acquisition of Spectrum Medical, a Gloucester-based medical device company valued at up to £1bn, and the acquisition of Therakos for $925 million. These transactions highlight CVC's active role in the medical device industry, which encompasses technologies that may relate to endoscopy devices, thereby indicating their relevance in this field.


11. Pmv

  • Website: pmv.eu
  • Type: Venture Capital
  • Headquarters: Brussels, Brussels, Belgium
  • Founded year: 2001
  • Headcount: 51-200
  • Number of deals in 2024: 11
  • LinkedIn: pmv-eu

Participatiemaatschappij Vlaanderen (PMV) is a public investment company based in Brussels, Belgium, founded in 2001. It provides a range of financing solutions, including loans and co-financing, to startups, scale-ups, and established businesses across various sectors such as real estate, clean tech, and life sciences. PMV also offers consulting services to help businesses navigate investment challenges and achieve sustainable growth. Notably, PMV has participated in funding rounds for companies like Exact Imaging, which raised $21.5 million in a Series C round, and FEops, which raised €6 million in Series B funding for personalized computer modeling in structural heart interventions. These transactions indicate PMV's involvement in the healthcare and medical technology sectors, which may include applications relevant to endoscopy devices, although their primary focus remains broader than just this niche.


12. Thuja Capital

  • Website: thujacapital.com
  • Type: Venture Capital
  • Headquarters: Utrecht, Utrecht, Netherlands
  • Founded year: 2006
  • Headcount: 1-10
  • Number of deals in 2024: 3
  • LinkedIn: thuja-capital

Thuja Capital Management BV is a venture capital firm based in Utrecht, Netherlands, founded in 2006. The firm specializes in healthcare investments, focusing on supporting innovative healthcare ventures from start-up to scale-up. Thuja Capital provides funding and strategic guidance to companies in the biotech and medtech sectors. Notably, they participated in the €14m Series A financing round for Gradient Denervation Technologies, which is developing an ultrasound-based catheter device, highlighting their engagement in medical technologies relevant to endoscopy. Additionally, they have been involved in funding rounds for Mellon Medical, which is working on the Switch® technology, further emphasizing their commitment to advancing medical innovations. Their portfolio reflects a strong interest in healthcare startups seeking investment to develop novel therapies and medical technologies.


13. BGV (BioGeneration Ventures)


BioGeneration Ventures (BGV) is a venture capital firm based in Naarden, North Holland, Netherlands, founded in 2006. The firm specializes in seed investments in innovative early-stage biotech companies, providing funding and support to help these companies develop disruptive solutions for unmet medical needs. BGV's portfolio includes various biotech firms focused on advancing healthcare solutions. Among their notable transactions, BGV led a €6 million financing round for Mellon Medical, which is developing the Switch® technology aimed at market introduction in late 2019/early 2020. This technology is relevant to the endoscopy device sector, showcasing BGV's engagement with companies that could impact this field. Other investments include SurgVision, Phosphoenix, Tiga TX, and Tessellate BIO, further emphasizing their focus on innovative healthcare solutions.


14. Astorg

  • Website: astorg.com
  • Type: Private Equity
  • Headquarters: Luxembourg
  • Founded year: 1998
  • Headcount: 51-200
  • Number of deals in 2024: 8
  • LinkedIn: astorg

Astorg is a private equity firm based in Luxembourg, founded in 1998, with a focus on investing in global B2B companies. They manage €22 billion in assets and specialize in providing capital, strategic guidance, and governance to management teams across various sectors, including healthcare, technology, and business services. In 2024, Astorg made significant acquisitions, including Cook Medical's Reproductive Health Portfolio and Hamilton Thorne, a company involved in advanced reproductive technologies. These transactions highlight their commitment to the healthcare sector, which may encompass endoscopy devices, as they seek to create long-term value through disciplined investment processes and strong partnerships with entrepreneurs.


15. Vesalius Biocapital Arkiv


Vesalius Biocapital Partners Sàrl is a venture capital firm based in Woluwe-Saint-Pierre, Brussels, Belgium, founded in 2007. The firm specializes in providing funding and strategic support to innovative life science companies across Europe, focusing on therapeutics, medical devices, and diagnostics. Notably, Vesalius Biocapital has participated in significant funding rounds for companies like Humedics, which is involved in medical technology, and Exact Imaging, which has developed advanced imaging solutions that could relate to endoscopic procedures. Their investment strategy includes assisting startups with capital, business optimization, and connections to industry leaders, positioning them as a key player in the life sciences and medical device sectors.


16. Capricorn Partners


Capricorn Partners is a venture capital firm based in Leuven, Flanders, Belgium, founded in 1993. The firm specializes in venture capital, growth capital, and quoted equity funds, focusing on innovative companies across various sectors, including digital technologies, health, and clean technologies. Capricorn Partners aims to create both financial returns and strategic value for its clients through responsible investing. Notably, they have been involved in significant transactions in the healthcare sector, such as multiple funding rounds for Sequana Medical, which has developed the alfapump technology for managing abdominal fluid. This technology has implications for endoscopic procedures, showcasing Capricorn's engagement in the medical device landscape. Additionally, their investment in Minze Health, which focuses on digital health solutions for urinary tract problems, further illustrates their active role in the health technology space.


17. Innovation Industries


Innovation Industries is a venture capital firm based in Amsterdam, Netherlands, founded in 2017. The firm specializes in deep tech investments, focusing on sectors such as industrial tech, med tech, and food & agri tech. Their mission is to catalyze growth in technology companies that can transform industries, addressing the funding challenges faced by these businesses. Notably, Innovation Industries has invested in Microsure, a company developing robot-assisted microsurgery technologies, which is highly relevant to the endoscopy device sector. They participated in multiple funding rounds for Microsure, including a €38M Series B2 round aimed at advancing the development of their microsurgical robot, MUSA-3. Additionally, they have invested in Cassini Technologies, which is developing a diagnostic platform for cataract surgery, and Onera Health, which focuses on polysomnography systems. These investments highlight their commitment to supporting innovative medical technologies that could have applications in endoscopy and related fields.


18. Holland Capital

  • Website: hollandcapital.nl
  • Type: Venture Capital
  • Headquarters: Amsterdam, North Holland, Netherlands
  • Founded year: 1981
  • Headcount: 11-50
  • Number of deals in 2024: 3
  • LinkedIn: holland-venture

Holland Capital is a venture capital and private equity investment firm based in Amsterdam, Netherlands, founded in 1981. The firm specializes in providing growth financing and buy-out capital to small and medium-sized enterprises across various sectors, including technology, healthcare, and agrifood. With over 40 years of experience, Holland Capital actively supports its portfolio companies to achieve optimal growth. Notably, they have invested in companies like Ventinova and Sirius Medical. Ventinova, which raised funds in 2013 and 2015, is involved in innovative medical technologies, while Sirius Medical has secured significant funding in recent years for its surgical tumor location software, indicating a focus on advancing healthcare solutions that could relate to endoscopy devices.


19. Invest-NL

  • Website: invest-nl.nl
  • Type: Venture Capital
  • Headquarters: Amsterdam, North Holland, Netherlands
  • Founded year: 2020
  • Headcount: 51-200
  • Number of deals in 2024: 17
  • LinkedIn: invest-nl

Invest-NL is an impact investment firm based in Amsterdam, Netherlands, founded in 2020. They focus on financing sustainable and innovative projects, particularly in the energy and technology sectors. Invest-NL aims to support entrepreneurs with promising plans for societal transitions by mobilizing capital from various sources. Notably, they have invested in Microsure, a company specializing in robot-assisted microsurgery, which raised €38M in Series B2 funding with their participation. This funding is intended for the development of a microsurgical robot, MUSA-3, which is relevant to the endoscopy device field. Additionally, they led a previous funding round for Microsure, further demonstrating their commitment to medical technology. Other investments include Sirius Medical and AMT Medical, both of which are involved in innovative medical solutions, reinforcing Invest-NL's position as a relevant player in the medical device investment landscape.



Endoscopy Device Insights: Key Investors in Benelux


InvestorHeadquarterSizeFoundedDeals 2024
European Innovation Council (EIC)Brussels, Brussels, Belgium201-500195857
European Investment Bank (EIB)Luxembourg1001-5000195899
Life Sciences Partners (LSP)Amsterdam, North Holland, Netherlands11-50198715
Gilde HealthcareUtrecht, Utrecht, Netherlands51-200198212
Brabantse Ontwikkelings Maatschappij (BOM)Tilburg, North Brabant, Netherlands51-200198310
GimvAntwerp, Flanders, Belgium51-20019808
NoshaqBelgium11-50198511
NLC - The European Healthtech Venture BuilderAmsterdam, North Holland, Netherlands51-20020146
Exor N.V.Amsterdam, North Holland, Netherlands11-50200926
CvcLuxembourg1001-5000200516
PmvBrussels, Brussels, Belgium51-200200111
Thuja CapitalUtrecht, Utrecht, Netherlands1-1020063
BGV (BioGeneration Ventures)Naarden, North Holland, Netherlands1-1020066
AstorgLuxembourg51-20019988
Vesalius Biocapital ArkivWoluwe-Saint-Pierre, Brussels, Belgium1-1020078
Capricorn PartnersLeuven, Flanders, Belgium11-5019935
Innovation IndustriesAmsterdam, North Holland, Netherlands11-50201710
Holland CapitalAmsterdam, North Holland, Netherlands11-5019813
Invest-NLAmsterdam, North Holland, Netherlands51-200202017


Want to find more investors focusing on the endoscopy device industry?

If you want to find more investors that are active in the endoscopy deviceindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!